BFRI
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
9.01M
EVO
Price
$3.48
Change
+$0.11 (+3.26%)
Updated
Sep 5 closing price
Capitalization
1.21B
59 days until earnings call
Interact to see
Advertisement

BFRI vs EVO

Header iconBFRI vs EVO Comparison
Open Charts BFRI vs EVOBanner chart's image
Biofrontera
Price$0.84
Change-$0.00 (-0.00%)
Volume$77.52K
Capitalization9.01M
Evotec SE
Price$3.48
Change+$0.11 (+3.26%)
Volume$85.94K
Capitalization1.21B
BFRI vs EVO Comparison Chart in %
Loading...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BFRI vs. EVO commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and EVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (BFRI: $0.84 vs. EVO: $3.48)
Brand notoriety: BFRI and EVO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 32% vs. EVO: 131%
Market capitalization -- BFRI: $9.01M vs. EVO: $1.21B
BFRI [@Pharmaceuticals: Generic] is valued at $9.01M. EVO’s [@Pharmaceuticals: Generic] market capitalization is $1.21B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 1 FA rating(s) are green whileEVO’s FA Score has 1 green FA rating(s).

  • BFRI’s FA Score: 1 green, 4 red.
  • EVO’s FA Score: 1 green, 4 red.
According to our system of comparison, both BFRI and EVO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 3 TA indicator(s) are bullish while EVO’s TA Score has 3 bullish TA indicator(s).

  • BFRI’s TA Score: 3 bullish, 5 bearish.
  • EVO’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, EVO is a better buy in the short-term than BFRI.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а -4.72% price change this week, while EVO (@Pharmaceuticals: Generic) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

EVO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EVO($1.21B) has a higher market cap than BFRI($9.01M). EVO YTD gains are higher at: -16.346 vs. BFRI (-22.541). BFRI has higher annual earnings (EBITDA): -15.28M vs. EVO (-121.33M). EVO has more cash in the bank: 356M vs. BFRI (7.25M). BFRI has less debt than EVO: BFRI (5M) vs EVO (107M). EVO has higher revenues than BFRI: EVO (777M) vs BFRI (39.2M).
BFRIEVOBFRI / EVO
Capitalization9.01M1.21B1%
EBITDA-15.28M-121.33M13%
Gain YTD-22.541-16.346138%
P/E Ratio0.89N/A-
Revenue39.2M777M5%
Total Cash7.25M356M2%
Total Debt5M107M5%
FUNDAMENTALS RATINGS
EVO: Fundamental Ratings
EVO
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BFRIEVO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 24 days ago
79%
Bullish Trend about 1 month ago
69%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDGRX13.000.02
+0.15%
Copeland Dividend Growth Fund Class A
EQNTX23.45N/A
N/A
MFS Equity Income R3
TEQKX12.91N/A
N/A
Nuveen Emerging Markets Eq Idx A
BMSLX15.44N/A
N/A
MFS Blended Research Mid Cap Eq I
SKSEX31.22-0.03
-0.10%
AMG GW&K Small Cap Value N

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+0.64%
ACET - BFRI
25%
Poorly correlated
+1.00%
DVAX - BFRI
23%
Poorly correlated
+0.80%
HCM - BFRI
23%
Poorly correlated
+7.61%
LNTH - BFRI
23%
Poorly correlated
+1.73%
EVO - BFRI
23%
Poorly correlated
+3.26%
More